Article info

Download PDFPDF
Six-year outcomes of antivascular endothelial growth factor monotherapy for polypoidal choroidal vasculopathy

Authors

  1. Correspondence to Dr Taiichi Hikichi, Hikichi Eye Clinic, Kita-sky Build, Sapporo 060-0807, Japan; thikichi{at}hikichi-eye.jp
View Full Text

Citation

Hikichi T
Six-year outcomes of antivascular endothelial growth factor monotherapy for polypoidal choroidal vasculopathy

Publication history

  • Received March 9, 2017
  • Revised April 20, 2017
  • Accepted April 23, 2017
  • First published May 25, 2017.
Online issue publication 
December 15, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.